Product Portfolio
At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies, providing quality generics and biosimilars, and finding new ways to deliver these treatments to as many people as possible.
Products are listed alphabetically by brand name. This is not complete medical or product information. Click on the highlighted links next to the product names for complete prescribing information, including important safety information.
If you have a medical condition, promptly see your physician or other healthcare provider.
Showing 106 results
Mekinist® (trametinib)
(tablets, for oral use)Mayzent® (siponimod)
(tablets, for oral use)Maxitrol® (neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension)
(neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension)ResourcesMaxitrol® (neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment)
(neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment)ResourcesMaxidex® (dexamethasone ophthalmic suspension) 0.1%
(dexamethasone ophthalmic suspension)LUTATHERA® (lutetium Lu 177 dotatate)
(injection, for intravenous use)Lotrel® (amlodipine besylate and benazepril hydrochloride)
(capsules)LOCAMETZ® (kit for the preparation of gallium Ga 68 gozetotide injection) (for intravenous use)
(for intravenous use)Lescol® XL (fluvastatin sodium)
(extended-release tablets for oral use)Leqvio® (inclisiran)
(inclisiran)
Pagination
- ‹ Previous page
- …
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- …
- › Next page